BSE filing, NSE: VANTAGE. Summary written from the filing by ALFA Finder's alert engine.
Anupam Finserv Ltd: key numbers
- Share price
- ₹1.63
- Market cap
- ₹30.93 Cr
- Revenue (annual)
- ₹4.88 Cr
- Net profit (annual)
- ₹1.95 Cr
- P/E (TTM)
- 14.2×Sector 19.7×
- Promoter holding
- 51.75%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anupam Finserv Ltd
All →Anupam Finserv Board Meeting Date
Anupam Finserv scheduled a Board meeting for 29 October 2026. It will consider and approve standalone unaudited results for the quarter and half-year ended 30 September 2026.
Anupam Finserv Annual General Meeting
Anupam Finserv Limited held its 35th Annual General Meeting on September 30, 2026. Shareholders approved the issuance of convertible warrants on a preferential allotment basis.
Anupam Finserv Annual Report
Anupam Finserv filed its FY 2025-26 Annual Report and 35th AGM notice with BSE. A corrigendum revised the AGM date to September 30 and updated preferential warrant issue terms.
Anupam Finserv Annual General Meeting
Anupam Finserv issued a corrigendum to its 35th AGM notice, rescheduling the meeting to 30 September 2026. It revised the warrant price and consideration to Rs.80 lakh.
Anupam Finserv Annual General Meeting
Anupam Finserv Ltd has issued a notice for its 35th Annual General Meeting to be held on September 10, 2026, via video conferencing.
Anupam Finserv Annual General Meeting
Anupam Finserv Limited issued a notice for its 35th Annual General Meeting scheduled for September 10, 2026. The meeting will address financial statements, director appointments, and related party transactions.
- Value
- ₹55.00 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.